reduction of inflammation, treatment of rheumatoid arthritis, treatment of giant cell arteritis, treatment of cytokine release syndrome, improvement of systemic juvenile idiopathic arthritis, potential treatment for COVID-19 related inflammation

Elevated Cholesterol Levels, Gastrointestinal Perforation, Headache, Hypertension, Increased Liver Enzymes, Infections, Infusion Reactions, Neutropenia, Rash

Tocilizumab is a prescription medication used primarily to treat certain autoimmune conditions, such as rheumatoid arthritis and cytokine release syndrome. The dosage of tocilizumab can vary based on the condition being treated, the patient’s weight, and other individual factors. Here are some general guidelines: 1. **Rheumatoid Arthritis (RA):** – For adults, the typical dosage is 4 mg/kg administered as an intravenous infusion every four weeks. This can be increased to 8 mg/kg based on clinical response, with a maximum dose of 800 mg per infusion. 2. **Systemic Juvenile Idiopathic Arthritis (SJIA) and Polyarticular Juvenile Idiopathic Arthritis (PJIA):** – For children, the dosage is typically based on body weight. For SJIA, it is usually 12 mg/kg for patients weighing less than 30 kg and 8 mg/kg for those weighing 30 kg or more, administered every two weeks. For PJIA, the dosage is 10 mg/kg for patients weighing less than 30 kg and 8 mg/kg for those weighing 30 kg or more, administered every four weeks. 3. **Cytokine Release Syndrome (CRS):** – The dosage for CRS is typically 8 mg/kg for patients weighing 30 kg or more and 12 mg/kg for those weighing less than 30 kg, administered as a single intravenous infusion. Additional doses may be given if needed. It’s important to note that these are general guidelines, and the exact dosage should be determined by a healthcare professional based on the specific needs of the patient. Always consult with a healthcare provider for personalized medical advice.

Rheumatoid arthritis, giant cell arteritis, cytokine release syndrome, systemic juvenile idiopathic arthritis, covid-19

Tocilizumab has a generally favorable safety profile.

No Interactions Reported

$1,000 – $3,000

$1500-$2,000 per dose.